O
131030
vs
M
MDLN
Over the past 12 months, Optus Pharmaceutical Co Ltd has significantly outperformed MDLN, delivering a return of +33% compared to the MDLN's 21% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
9 010
KRW
|
|||||
|
M
|
Medline Inc
NASDAQ:MDLN
|
47.92
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
131030, MDLN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
O
|
Optus Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
M
|
Medline Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
131030, MDLN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
|||||||||
|
M
|
Medline Inc
NASDAQ:MDLN
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
M
|
Medline Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
M
|
Medline Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
M
|
Medline Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
M
|
Medline Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
M
|
Medline Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
M
|
Medline Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
M
|
Medline Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
M
|
Medline Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
131030, MDLN
Performance Gap
131030, MDLN
Performance By Year
131030, MDLN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
|
| JP |
|
Hoya Corp
TSE:7741
|
|
| CH |
|
Alcon AG
SIX:ALC
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
